Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravesical botulinum toxin gel instillation for overactive bladder in women
2012-005344-15Phase 2Completed
- Sponsor
- Adyton
- Start
- Jan 2013
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 2, double-blind trial of botulinum toxin type A and Dimethyl sulfoxide in overactive bladder (OAB) (4 arms), sponsored by Adyton. Primary endpoint: Change from baseline in the mean number of micturitions per 24 hours. Started Jan 2013; status: completed.
02
Drugs
botulinum toxin type ADimethyl sulfoxide
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on 2012-005344-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005344-15.